- Home
- BCDA vs LEDS Comparison
BCDA vs LEDS Comparison
Compare BCDA & LEDS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BCDA
- LEDS
- Stock Information
- Founded
- BCDA N/A
- LEDS 2005
- Country
- BCDA United States
- LEDS Taiwan
- Employees
- BCDA N/A
- LEDS N/A
- Industry
- BCDA Biotechnology: Pharmaceutical Preparations
- LEDS Semiconductors
- Sector
- BCDA Health Care
- LEDS Technology
- Exchange
- BCDA Nasdaq
- LEDS Nasdaq
- Market Cap
- BCDA 7.9M
- LEDS 9.4M
- IPO Year
- BCDA N/A
- LEDS 2010
- Fundamental
- Price
- BCDA $2.05
- LEDS $1.38
- Analyst Decision
- BCDA Strong Buy
- LEDS
- Analyst Count
- BCDA 1
- LEDS 0
- Target Price
- BCDA $25.00
- LEDS N/A
- AVG Volume (30 Days)
- BCDA 31.3K
- LEDS 79.0K
- Earning Date
- BCDA 11-13-2024
- LEDS 01-10-2025
- Dividend Yield
- BCDA N/A
- LEDS N/A
- EPS Growth
- BCDA N/A
- LEDS N/A
- EPS
- BCDA N/A
- LEDS N/A
- Revenue
- BCDA $71,000.00
- LEDS $5,183,000.00
- Revenue This Year
- BCDA N/A
- LEDS N/A
- Revenue Next Year
- BCDA N/A
- LEDS N/A
- P/E Ratio
- BCDA N/A
- LEDS N/A
- Revenue Growth
- BCDA N/A
- LEDS N/A
- 52 Week Low
- BCDA $1.84
- LEDS $0.92
- 52 Week High
- BCDA $10.80
- LEDS $2.29
- Technical
- Relative Strength Index (RSI)
- BCDA 42.16
- LEDS 50.13
- Support Level
- BCDA $2.00
- LEDS $1.21
- Resistance Level
- BCDA $2.14
- LEDS $1.70
- Average True Range (ATR)
- BCDA 0.16
- LEDS 0.12
- MACD
- BCDA -0.00
- LEDS 0.01
- Stochastic Oscillator
- BCDA 15.91
- LEDS 24.00
About BCDA BioCardia Inc.
BioCardia Inc is a clinical-stage company developing cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases with significant unmet medical needs. Its two cell therapy platforms derived from the bone marrow. CardiAMP autologous mononuclear cell therapy platform is being advanced for two clinical indications: ischemic heart failure with reduced ejection fraction (HFrEF) and refractory angina resulting from chronic myocardial ischemia (CMI). Its immunomodulatory allogeneic mesenchymal stem cell (MSC) therapy platform is being an "off the shelf" cell therapy for two clinical indications: the treatment of ischemic HFrEF (CardiALLO), which is actively enrolling, and acute respiratory distress syndrome (ARDS).
About LEDS SemiLEDS Corporation
SemiLEDs Corp develops, manufactures, and sells light-emitting diode chips and LED components. The company's products include LED Chips, LED Components, and Lighting Products. Its products are used for general lighting applications, including street lights and commercial, industrial, system, and residential lighting; specialty industrial applications, such as ultraviolet, or Ultraviolet, curing of polymers, LED light therapy in medical/cosmetic applications, counterfeit detection, LED lighting for horticulture applications, architectural lighting and entertainment lighting. Substantial revenue is generated from the sale of LED components products. Geographically, it derives a majority of its revenue from Japan.